Large gap with delayed quotes
|
Last quote
10/16/2026
-
02:00:00
|
Bid
10/16/2026 -
10:11:33
|
Bid Volume |
Ask
10/16/2026 -
10:11:33
|
Ask Volume |
|---|---|---|---|---|
|
214.42
+4.77
(
+2.28% )
|
193.88
|
100 |
235.55
|
100 |
Analysis date: 13.10.2026
Global Evaluation
Slightly positive
Slightly positive
The stock is classified in the slightly positive zone since 08.09.2026.
Quality
Very weak
Very weak
One star since 08.09.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 07.07.2026 at a price of 247.72.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 08.09.2026.
4wk Rel Perf
-16.35%
-16.35%
The four-week dividend-adjusted underperformance versus SP500 is 16.35%.
Risk
Low
Low
The stock has been on the low-sensitivity level since 08.05.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -1.36%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.60%.
Mkt Cap in $bn
14.07
14.07
With a market capitalization >$8bn, JAZZ PHARMACEUTICALS is considered a large-cap stock.
G/PE Ratio
1.31
1.31
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
6.85
6.85
The estimated PE is for the year 2029.
LT Growth
8.94%
8.94%
The annualized growth estimate is for the current year to 2029.
Avg. Nb analysts
14
14
Over the last seven weeks, an average of 14 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
7
7
For 1% of index variation, the stock varies on average by 0.07%.
Correlation
0.01
0.01
Stock movements are totally independent of index variations.
Value at Risk
12.64
12.64
The value at risk is estimated at USD 12.64. The risk is therefore 6.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
06.04.2011
06.04.2011